Is MLN 2238 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use MLN 2238? Is MLN 2238 safe for nursing mother and child? Does MLN 2238 extracts into breast milk? Does MLN 2238 has any long term or short term side effects on infants? Can MLN 2238 influence milk supply or can MLN 2238 decrease milk supply in lactating mothers?
Answer by DrLact: About MLN 2238 usage in lactation
No information is available on the clinical use of MLN 2238 during breastfeeding. Because its half-life is about 9.5 days, it is likely to accumulate in the infant. It is also given in combination with leflunomide and dexamethasone, which may increase the risk to the infant. The manufacturer recommends that breastfeeding be discontinued during MLN 2238 therapy and for 90 days after the last dose.
Alternate Drugs
Bevacizumab(Low Risk)
Vincristine(Dangerous)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Dactinomycin(Dangerous)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Imatinib(Unsafe)
Cladribine(Dangerous)
Gemcitabine(Dangerous)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Vinblastine(Dangerous)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Bleomycin(Dangerous)
Azelaic Acid(Safe)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Vinorelbine(Dangerous)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Letrozole(Dangerous)
Alemtuzumab(Low Risk)
Exemestane(Dangerous)
Dasatinib(Unsafe)
Rituximab(Low Risk)
Allopurinol(Safe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)